VERA THERAPEUTICS INC's ticker is VERA and the CUSIP is 92337R101. A total of 56 filers reported holding VERA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $162,000 | – | 11,939 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Altium Capital Management LP | 714,000 | $25,832,520 | 10.54% |
| COMMODORE CAPITAL LP | 2,475,000 | $89,545,500 | 6.11% |
| Sofinnova Investments, Inc. | 2,793,987 | $101,086,450 | 5.25% |
| Eversept Partners, LP | 2,043,214 | $73,923,483 | 5.06% |
| Portman Ltd | 32,795 | $1,186,523 | 4.48% |
| Kynam Capital Management, LP | 1,543,669 | $55,849,944 | 4.31% |
| First Light Asset Management, LLC | 1,005,723 | $36,387,058 | 3.19% |
| Logos Global Management LP | 950,000 | $34,371,000 | 2.79% |
| Cutter Capital Management, LP | 230,000 | $8,321,400 | 2.51% |
| Avoro Capital Advisors LLC | 4,309,590 | $155,920,966 | 2.08% |